Loibl, S., Loirat, D., Tolaney, S. M., Punie, K., Oliveira, M., Rugo, H. S., Bardia, A., Hurvitz, S. A., Brufsky, A., Kalinsky, K., Cortés, J., O’Shaughnessy, J., Dieras, V. C., Carey, L. A., Gianni, L., Gharaibeh, M., Moore, L., Shi, L., & Piccart, M. (2021). 257P Health-related quality of life (HRQoL) in the ASCENT study of sacituzumab govitecan (SG) in metastatic triple-negative breast cancer (mTNBC). Annals of Oncology, 32, S472–S473. https://doi.org/10.1016/j.annonc.2021.08.540